Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Ironwood Pharmaceuticals Inc shares valued at $7,745 were sold by MCCOURT Thomas A on May 16 ’25. At $0.58 per share, MCCOURT Thomas A sold 13,353 shares. The insider’s holdings dropped to 1,147,281 shares worth approximately $0.77 million following the completion of this transaction.
Also, Gaskins Tammi L sold 2,563 shares, netting a total of over 1,487 in proceeds. Following the sale of shares at $0.58 each, the insider now holds 242,596 shares.
Before that, MCCOURT Thomas A had added 14,661 shares to its account. In a trade valued at $8,650, the Officer bought Ironwood Pharmaceuticals Inc shares for $0.59 each.
As published in a research note from Wells Fargo on April 15, 2025, Ironwood Pharmaceuticals Inc [IRWD] has been rated down from an Overweight to an Equal weight. Analysts at Jefferies downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in mid April. As of April 14, 2025, Citizens JMP has decreased its “Mkt outperform” rating to a “Mkt perform” for IRWD. Earlier on September 09, 2024, Leerink Partners initiated its rating. Their recommendation was “a Market perform” for IRWD stock.
Analyzing IRWD Stock Performance
On last trading session,, Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] plunged -7.39% to $0.67. The stock’s lowest price that day was $0.6501, but it reached a high of $0.7473 in the same session. During the last five days, there has been a surge of approximately 17.06%. Over the course of the year, Ironwood Pharmaceuticals Inc shares have dropped approximately -84.91%.
Support And Resistance Levels for Ironwood Pharmaceuticals Inc (IRWD)
RSI (Relative Strength Index) is 47.77 on the 14-day chart, showing neutral technical sentiment.
Is Ironwood Pharmaceuticals Inc subject to short interest?
Stocks of Ironwood Pharmaceuticals Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.57 million shares to 8.23 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 8.8 million shares. A decline of -6.95% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.9 of the overall float, the days-to-cover ratio (short ratio) decline to 2.9.
Which companies own the most shares of Ironwood Pharmaceuticals Inc (IRWD)?
In terms of Ironwood Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 4 in the next 12 months, up nearly 455.56% from the previous closing price of $0.72. Analysts anticipate Ironwood Pharmaceuticals Inc stock to reach 7 by 2025, with the lowest price target being 1. In spite of this, 2 analysts ranked Ironwood Pharmaceuticals Inc stock as Buy at the end of 2025. On August 08, 2024, CapitalOne assigned a price target of “an Equal weight” to the stock and downgraded coverage with a $4.
